Literature DB >> 4734412

Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor.

R Bluestone, L S Goldberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4734412      PMCID: PMC1006033          DOI: 10.1136/ard.32.1.50

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Comparison of the effect of plasmapheresis and penicillamine on the level of circulating rheumatoid factor.

Authors:  I A JAFFE
Journal:  Ann Rheum Dis       Date:  1963-03       Impact factor: 19.103

2.  Essential cryoglobulinemia. Immunologic studies before and after penicillamine therapy.

Authors:  L S Goldberg; E V Barnett
Journal:  Arch Intern Med       Date:  1970-01

3.  Penicillamine in rheumatoid arthritis.

Authors:  J Zuckner; R H Ramsey; R W Dorner; G E Gantner
Journal:  Arthritis Rheum       Date:  1970 Mar-Apr

4.  Observations on the treatment of rheumatoid disease with penicillamine.

Authors:  J R Golding; J V Wilson; A T Day
Journal:  Postgrad Med J       Date:  1970-10       Impact factor: 2.401

5.  [Penicillamine and rheumatoid polyarthritis (study of 9 cases)].

Authors:  J P Camus; P Guillien; J Crouzet; A Schaeffer; J A Lièvre
Journal:  Ann Med Interne (Paris)       Date:  1970-02

6.  Effects of therapeutically useful thiols (DL-penicillamine and alpha-mercaptopropionylglycine) on immunoglobulins.

Authors:  G Virella; M F Lopes-Virella
Journal:  Clin Exp Immunol       Date:  1970-07       Impact factor: 4.330

  6 in total
  22 in total

1.  The influence of drug therapy on serum immunoglobulin profiles in rheumatoid arthritis.

Authors:  A J Swannell; J Watkins
Journal:  Proc R Soc Med       Date:  1977

Review 2.  Penicillamine types in the sclerodermas.

Authors:  T H Tio
Journal:  Proc R Soc Med       Date:  1977

3.  Immunotoxicity of immunotherapeutic agents.

Authors:  A G Johnson; J Regal
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Some immunological effects of penicillamine.

Authors:  D M Chen; G Di Sabato; L Field; A A Gallo; S Harshman
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

5.  Effect of drug therapy on circulating and synovial fluid Ig-secreting cells in rheumatoid arthritis.

Authors:  S Al-Balaghi; H Ström; E Möller
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

6.  Controlled trial of D-penicillamine with low dosis in the treatment of chronic liver diseases.

Authors:  H Nakano; S Ohnishi; T Sugiyama; M Miyamura; H Imura; Y Yamamoto; K Ito
Journal:  Gastroenterol Jpn       Date:  1980

7.  Effect of penicillamine therapy on circulating immune complexes in rheumatoid arthritis.

Authors:  I Mohammed; D Barraclough; E J Holborow; B M Ansell
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

8.  The effect of D-penicillamine on polymorphonuclear leukocyte function.

Authors:  H Chwalinska-Sadowska; J Baum
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

9.  Pertussis vaccine oedema: an experimental model for the action of penicillamine-like drugs.

Authors:  E Arrigoni-Martelli; E Bramm; E C Huskisson; D A Willoughby; P A Dieppe
Journal:  Agents Actions       Date:  1976-09

10.  Correlative studies of rheumatoid factors and anti-viral antibodies in patients with rheumatoid arthritis.

Authors:  A S Ferraro; M M Newkirk
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.